Clinical Trial Shows Berberine May Impact Gut Bacteria and Heart Health
A recent clinical trial involving 23 participants with coronary artery disease investigated the effects of berberine, a plant compound found in various plants such as barberry. The trial, reported on October 21, 2026, indicated that participants taking berberine experienced a greater reduction in LDL cholesterol, often referred to as 'bad' cholesterol, compared to those receiving standard treatment alone. Additionally, decreases in several inflammation markers were noted, alongside changes in gut bacteria that produce short-chain fatty acids, which are important for metabolic health.
The participants in the trial had previously undergone procedures to open narrowed heart arteries. Twelve individuals added berberine to their usual heart medications, gradually increasing their dosage, while 11 continued with standard treatment alone. Researchers measured cholesterol levels, inflammation, and blood vessel function before and after treatment, and they also analyzed stool samples to track changes in gut bacteria and their metabolic byproducts.
While the results showed promising trends, researchers cautioned that the trial does not establish a causal relationship between the changes in gut bacteria and the observed reduction in cholesterol levels. The small sample size and short duration of the study were identified as significant limitations, necessitating further research to confirm these findings.
Berberine has a long history of use in traditional medicine, particularly in Traditional Chinese Medicine, and has been studied for its potential benefits in improving metabolic health, especially for conditions like Type 2 diabetes and prediabetes. A meta-analysis of 14 randomized trials involving over 1,000 participants found that berberine, combined with lifestyle modifications, led to significant improvements in blood sugar and lipid levels.
Exploring the Link Between Gut Bacteria and Metabolic Health
In this trial, researchers observed an increase in certain gut bacteria that produce short-chain fatty acids, which may help regulate inflammation and support metabolic health. They also noted changes in other substances produced by gut bacteria during amino acid breakdown, some of which were linked to shifts in blood fat levels. The connection between gut health and heart health is becoming increasingly recognized, as substances from gut bacteria can enter the bloodstream and influence inflammation and fat processing.
Implications of Berberine on Heart Health and Gut Microbiota
Despite these encouraging findings, the researchers emphasized that larger studies are needed to determine whether berberine can reliably improve heart health over time. The gut microbiota of patients with chronic heart failure tends to have a lower abundance of beneficial butyrate-producing bacteria, which are thought to play a role in cardiovascular health. Recent studies have shown associations between specific gut bacteria and the onset or progression of cardiovascular disease.
The researchers concluded that while the trial provides valuable insights, it is insufficient to confirm that berberine improves cardiovascular outcomes. They recommended incorporating fiber-rich foods such as beans, lentils, oats, whole grains, fruits, and vegetables into the diet to support beneficial gut bacteria. Furthermore, individuals considering berberine supplementation should consult a healthcare provider, especially since participants in the trial added it to their usual heart medications and it should not replace prescribed treatments. Overall, the findings suggest that gut microbes may have a more significant role in heart health than previously understood, and dietary fiber remains a crucial element in maintaining gut and heart health.




